Tirzepatide is a novel synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This unique dual-incretin mechanism distinguishes it from single-receptor GLP-1 agonists and has generated considerable interest in metabolic disease research.
In preclinical and clinical research settings, tirzepatide has demonstrated pronounced effects on glycaemic control, insulin secretion, and appetite regulation. Its dual receptor activity is thought to produce synergistic effects on beta-cell function, gastric emptying, and energy homeostasis, making it a valuable tool for researchers studying type 2 diabetes pathophysiology, obesity mechanisms, and cardiometabolic risk.
This 30mg research vial of tirzepatide is supplied as a lyophilised powder with a purity of greater than 98%, as confirmed by HPLC analysis.
For optimal stability, lyophilised tirzepatide should be stored at -20°C and protected from light. Once reconstituted, the solution should be kept at 4°C and used within a short period.
Supplied by Peptician exclusively for in vitro and laboratory research use.
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.5 g/mol
Purity
>98%
CAS Number
2023788-19-2
Form
Lyophilised Powder
Research Applications
Metabolic disease research, Obesity and adiposity studies, Glycaemic regulation, Insulin sensitivity and beta-cell function, Cardiometabolic risk research, Appetite and energy homeostasis
For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.
Reviews
There are no reviews yet.